POLD2 and bladder transitional cell carcinoma: Several recent studies have also confirmed the high expression levels of POLD2 in the pathogenesis of various malignancies, including breast cancer,19 glioblastoma,20 multiple myeloma,21 and bladder urothelial carcinoma.22